Posted on July 1, 2009 at 9:40 AM
Filed under: Deal International | Intellectual property | Research and development
Tagged: Laboratorios Farmaceuticos Rovi , licensing , Novavax

With big pharmaceutical companies looking to load their pipelines and biotechnology firms looking for capital to keep afloat, licensing deals between the two are a mainstay of the industry. And as such, not every deal gets a mention here. But a transaction announced Tuesday involving Novavex Inc. (NASDAQ:NVAX) and the...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on June 3, 2009 at 1:20 PM
Filed under: Intellectual property | Movers & Shakers | Research and development
Tagged: chris christie , johnson & johnson , pfizer

It's official. New Jersey Republicans on Tuesday chose former U.S. Attorney Chris Christie as their gubernatorial candidate. He'll oppose Gov. Jon Corzine next fall.Which inspires us to resurface a quirky detail Christie revealed in financial disclosure statements and The Star-Ledger reported on last month. In 2004, he earned more than...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on May 4, 2009 at 4:09 PM
Filed under: Acquisitions | Joint Ventures and Alliances | Research and development
Tagged: Blackberry , Electronic Data Systems , Hewlett-Packard , Research in Motion

When Hewlett-Packard Co. (NYSE:HPQ) acquired Electronic Data Systems Corp. for $13.9 billion last year, it inherited an existing relationship with Research In Motion Ltd. (NASDAQ:RIMM). You see, prior to the August 2008 deal, EDS managed through its mobile workplace services business the BlackBerry accounts of about 500,000 spartphone users. On...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on April 29, 2009 at 2:53 PM
Filed under: Acquisitions | Best Practices | Case Studies | Corporate Strategy | Deal International | Divesting and Restructuring | Growth Strategy | Joint Ventures and Alliances | Outsourcing | Research and development | Trends
Tagged: Chris Viehbacher , Hexaxim , Merck , Merial , Phase III drugs , Sanofi-Aventis

After about five months on the job, Sanofi-Aventis SA (NYSE:SNY) chief executive Chris Viehbacher is making his presence felt as the company reports profits are up about 16% and confirmed 2009 guidance.Viehbacher, on the hunt for acquisitions, cut 14 drugs in development from its pipeline of 65 -- including four...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on March 6, 2009 at 3:04 PM
Filed under: Acquisitions | Best Practices | Deal International | Growth Strategy | Research and development
Tagged: Coca-Cola , Coke , Huiyuan Juice

With so many companies scaling back, it's nice to hear about one charging ahead, even if it is in China -- which is where Coca-Cola Co. (NYSE:KO), plans to invest $2 billion over three years. The Wall Street Journal China blog put the number in context, noting that from 1979...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on January 26, 2009 at 12:48 PM
Filed under: Acquisitions | Corporate Strategy | Integration | Research and development
Tagged: job cuts , Moody's , Pfizer , Wyeth

Stocks rose in part on the news of Pfizer Inc.'s $68 billion acquisition of rival Wyeth, which could prompt further consolidation in healthcare. While the synergistic deal would provide Pfizer with a broader range of products and help make up for the loss of patent protection for its cash cow...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on December 31, 2008 at 8:55 AM
Filed under: Corporate Strategy | Deal International | Joint Ventures and Alliances | Research and development
Tagged: Archemix Corp. , AstraZeneca plc , Forest Laboratories Inc. , GlaxoSmithKline plc , MAP Pharmaceuticals Inc. , Pierre Fabre Medicament , Roche Holding AG , Synta Pharmaceuticals Corp.

M&A in the drug world might be stalled, with Example No. 1 being Roche Holding AG's $44 billion bid for Genentech Inc., but the year is ending with a burst of licensing activity.   The week before Christmas, we reported in The Deal (subscription required) at least six deals that...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on December 18, 2008 at 3:25 PM
Filed under: Careers | People | Research and development
Tagged: arpa-e , department of energy , Energy Secretary , steven chu

In an earlier post, I looked at a new battery-manufacturing consortium that's likely to get a $1 billion boost from the Department of Energy. Incoming Energy Secretary Steven Chu, I noted, champions the idea of government investment in alt energy development. So, what other routes might such investment take after...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]

Posted on December 18, 2008 at 11:45 AM
Filed under: Joint Ventures and Alliances | Research and development
Tagged: 3M Corp. , johnson controls inc. , National Alliance for Advanced Transportation Battery Cell Manufacture , Saft SA

Fourteen U.S. companies are teaming up with Argonne National Laboratory to build a plant to make lithium-ion batteries for electric cars, The Wall Street Journal reported Thursday, and they'll seek $1 billion from the federal government to help. The report is noteworthy for several reasons.First, it shows the interest of...  Continue reading

[ Share ]  [ E-mail]  [ Comments (2) ]  [ Full Story ]

Posted on November 21, 2008 at 9:46 AM
Filed under: Acquisitions | Best Practices | Case Studies | Corporate Strategy | Deal International | Divesting and Restructuring | Joint Ventures and Alliances | People | Research and development | Trends
Tagged: Indra Nooyi , Massimo d'Amore , PepsiCo

As U.S. sales stall, PepsiCo Inc. is looking abroad to boost profits. Thursday, the Purchase, N.Y.-based beverage giant said it would invest up to $3 billion in Mexico -- where it has more than 40,000 employees -- over the next several years. Two billion dollars will go to R&D, manufacturing...  Continue reading

[ Share ]  [ E-mail]  [ Leave a Comment ]  [ Full Story ]